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Objective. To evaluate the possible migration of polymethylmethacrylate after injections in various corporal compartments
of Wistar rats. Methods. The experimental work consisted in the injection of PMMA in corporal compartments for later
histopathological analysis of the locations of implants and of distant ﬁltering organs. The dose applied in each implant was
of 0.2mL. The animals were divided into groups according to the location of the implant realized: group GB had intradermic
injections in the glabella. Group SD had subdermal injections in dorsal subcutaneous tissue cells. Group IP had intraperitoneal
injections in the abdomen. Group PD had intramuscular injections in the right rear leg. The rats were sacriﬁced 30 days after
realization of the implants and tissue samples from the lung, liver, spleen, and kidney, and locations of implantation were removed
for histopathological analysis. Results. Characteristic microspheres that were compatible with the presence of PMMA in any of the
histological slides analyzed were not observed. One animal had an amorphous exogenous substance, with a histiocytic reaction.
Twelve of the 16 lungs analyzed had locations of intraalveolar hemorrhaging. Two animals had nonspeciﬁc spleen alterations.
Conclusion. The histopathological analysis of this study found no PMMA microspheres in any of the tissues analyzed.
1.Introduction
In recent years for either aesthetic or reconstructive pur-
poses, a diversity of materials has been used as dermal ﬁllers.
The objective is to elevate the area treated by decreasing the
thickness of the skin in this region and by improving its
appearance [1].
Despitethelargenumberofpublicationsaboutthisissue,
theidealsubstanceforﬁllinghasstillnotbeenfound,because
the material must be safe, permanent, easy to apply, and have
a good cost-beneﬁt ratio and a low rate of complications [2–
6].
Inert materials tested for injectable microimplants in-
clude polymerized silicon, which began to be used in 1940,
[4] with the high risk of complications. Others such as
hyaluronic acid, fat grafts, and collagen are substances
quite commonly used today, but whose results have limited
duration [7].
PMMA was discovered and synthesized in 1902, by Otto
R¨ ohm, and was patented as Plexiglass in 1928. It has been
used in medicine since 1945 and now has a variety of
applications including bone cement and others [2].
In 1991, Gottfried Lemperle began to study polymethyl-
methacrylate (PMMA) to ﬁll in small skin deformities.
Lemperle et al. showed that PMMA was histological
biocompatible and did not generate inﬂammatory responses
when implanted under the skin [8]. Artecoll, a substance
to be used as a dermal ﬁller, was created by Roﬁl Medical
International. The product consists of microspheres of
PMMA with diameters from 30 to 40µm, in a bovine colloid2 ISRN Dermatology
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Figure 1: Photos of PMMA under electronic microscope (×800).
(a) Microspheres of PMMA of diﬀerent sizes with impurities in
bone cement. (b) Arteﬁll after washing and puriﬁcation of the
PMMA microspheres. source: Lemperle, 2003.
vehicle. It was thought to be a solution for a dermal ﬁller,
with rare collateral eﬀects and excellent long-term results
[9]. Nevertheless, with the increased popularity of its use,
there was an increase in the number of publications about
its complications.
According to Lemperle, these complications were due to
impurities that adhered to the microspheres. In 1994, the
Artecoll microspheres were modiﬁed, so that they would
have absolutely smooth and spherical surfaces (Figure 1)
[10]. In an attempt to decrease complications even more,
new techniques for the removal of impurities were utilized.
In 2006, a third generation was presented, called ArteFill,
with rigorous control in the puriﬁcation of the microspheres
now with diameters of 30–50µm[ 11].
PMMA skin implants are becoming popular and known
as bioplasty. An increasing number of doctors from a variety
of specialties are becoming trained to oﬀer bioplasty as
part of the services provided in their private practices [4].
Nevertheless, the procedures are not completely free of risk,
and a number of complications are related to the injection of
PMMA.
In Brazil, one of PMMA products is Metacrill (Nutricel,
RJ), which has been used for more than 8 years, and 30% of
Table 1: Groups division according to the location of the implant.
Group Compartment Local Number of animals
GB Intradermic Glabella 4
SD Subdermal Cervical region 4
IP Intraperitoneal Abdomen 4
MPD Intramuscular Right leg 4
its composition is PMMA microspheres with diameters 40–
60µm, in carboxymethyl-cellyulose coloid [12].
The literature about studies of migrations, inﬂammatory
response, composition, and safety is related to the Dutch
substance—Artecoll, which has a diﬀerent composition.
The objective of this study was to observe, through his-
topathological analysis, the possibility of the migration of
polymethylmetacrylate,afterinjectionsinvariousbodycom-
partments of Wistar rats.
2. Methods
This study was submited to the Commission of Ethics in the
Use of Animals of the Federal University of Santa Catarina
(UFSC) on June 20, 2007, and was approved on August 15,
2007, according to protocol PP00126.
The experiment utilized 16 adult female Wister rats
(Rattus norvegicus albinus, Rodentia:Mamalia), produced at
UFSC’s central breeding facility. The rats were 180 days old
and had an average weight of 300 grams.
The experimental study was conducted at the Laboratory
of Operating Technique and Experimental Surgery of the
Surgery Department of the Federal University at Santa Cata-
rina (TOCE-UFSC), where animals were maintained indi-
vidually in polyurethane cages of 40 × 32 × 16 centimeters,
under ambient temperature and lighting, maintaining the
day-night cycle and access to rations and water ad libitum.
The cages were cleaned every 48 hours, with replacement of
water and rations. The rats were observed for the presence
of strange behavior, signs of infection, and injuries caused by
mutilation,atsix-hourintervalsduringtheday,fortheentire
experiment.
The experimental group (n = 16) was divided into 4
sub-groups, each with 4 animals, which were individually
selected through a simple drawing and separated into groups
according to the location of the implant (Table 1).
2.1. Glabella Subgroup (Subgroup GB n = 4). The GB sub-
group included four animals which, after receiving anaes-
thesia, were injected with 0.2mL of PMMA in the glabella
region on the intradermal plane (Figure 2(b)). The animals
were submited to painless death induced 30 days after the
PMMA injection. For the histopathological procedure of this
group, the right eyeball of each animal was removed.
2.2. Subdermal Subgroup (Subgroup SD n = 4). The SD sub-
group included four animals which, after receiving anesthe-
sia,wereinjectedwith0.2mLofPMMAinthecervicaldorsalISRN Dermatology 3
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Figure 2: Metacrill. (a) Material used in the study. (b) Injection of 0.2mL of intradermal polymethylmetacrylate in the glabella region.
region on the subdermal plane (Figure 3(a)). These animals
were submited to a painless induced death 30 days after
the PMMA injection. For the histopathological procedure of
this group, the skin and subcutaneous cellular tissue were
removed from the implanted area of each animal.
2.3. Intraperitoneal Subgroup (Subgroup IP n = 4). The IP
sub-group included four animals which, after receiving
anesthesia, received injections of 0.2mL of PMMA in the
right hemiabdominal region on the intraperitoneal plane
(Figure 3(b)). These animals were submited to painless
induced death 30 days after the injection of PMMA. For
the histopathological procedure of this group, each animal’s
diaphragm muscle was removed.
2.4. Right Membrum Pelvinum Subgroup (MPD Subgroup
n = 4). The MPD subgroup included four animals which,
after receiving anesthesia, received injections of 0.2mL of
PMMA in the rear right leg on the intramuscular plane
(Figure 3(c)). These animals were submitted to a painless
induced death 30 days after the PMMA injection. For the
histopathological procedure of this group, the musculature
oftherightMembrum pelvinum ofeachanimalwasremoved.
2.5. Procedures. The anesthesia was applied through an in-
tramuscular injection of atropine, at a dose of 0.044 mil-
ligrams per kilo of live weight. Ten minutes later, they were
injectedwithxylazinechlorohydrateatadoseofﬁvemg/kgof
live weight and ketamine chlorhydrate at a dose of 10mg/kg
of live weight, both from the same syringe and applied
intramuscularly to the inner left thigh. The absence of reﬂex
movements,inresponsetopinchingthemembrumpelvinum,
was the method used to evaluate the eﬀectiveness of the
anesthesia. After conﬁrmation of the proper anesthetic eﬀect
and the removal of fur from the referred to locations, the
animals were submited to the PMMA injection procedures.
All the animals received implants of PMMA of the
Metacrill 10% (Figure 3(a)). According to information from
the manufacturer, it is composed of polymethylmetacrylate,
withadiameterof40–60µm,inacolloidmediumofcarboxy
glutonate hydrolactate of magnesium.
The dose utilized, in all cases, was 0.2mL of Metacrill
per animal, using a 3mL polyurethane syringe and a 25/7G
hypodermic needle.
All the animals were given anesthesia once again, with
the technique already described and submitted to a painless
induced death through inhalation of ethyl ether in a closed
chamber, and, after death, the following organs were re-
moved from all of the animals: right kidney, lungs, liver, and
spleen.
For the analysis of local migration, speciﬁc organs were
removed depending on the location of the injection. In
group GB, the entire eyeball was removed with part of the
attached optical muscles and nerve. In the animals of the SD
group, the skin with the subcutaneous cell tissue from the
implanted area was removed. In the IP and MPD groups,
respectively,thediaphragmandmusculatureoftherearright
leg were removed (Figure 5). These parts were then set in
formaldehyde and placed in recipients identiﬁed by num-
bers corresponding to each rat and respective group. The
histopathological analysis was conducted at the Instituto de
Diagn´ ostico An´ atomo Patol´ ogico (Institute of Pathological
Anatomy Diagnostics) (IDAP), in the city of Florian´ opolis,
by a single pathologist.
At the IDAP, since no nodulations or any alteration in
the macroscopy of the parts were found, a small random part
of the tissue was removed and included in paraﬃn, cut with
a manual microtome at a thickness of four micons. At each
cut, a morphometric microscopic, anatomical-pathological
analysis was conducted to verify the possible presence of a4 ISRN Dermatology
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Figure 3: Subdermal application of PMMA in the dorsal (a), intraperitoneal in the right hemi-abdominal (b), and intramuscularly in the
right membrum pelvinum (c).
material compatible with microspheres of injected PMMA.
An eﬀort was made to analyze the following cell types:
(i) polymorphonuclear cells (PMN),
(ii) mononuclear cells (MO),
(iii) foreign body giant Cells (GC),
(iv) macrophages,
(v) other cell types,
(vi) microspheres.
A total of 80 histological sections colored with hema-
toxylin/eosin were observed by a single medical pathologist,
using an optical microscope.
3. Results
3.1. Group GB. In the histological sections of the eyeball of
the four animals studied, all the visual structures, the optical
nerve, sclera, retina, cornea, and crystalline lens, did not
present any modiﬁcations to the morphological standard or
any inﬂammatory inﬁltration (Figure 4(a)).
The sections of the spleen analyzed had normal histo-
logical standards with white and red pulp and no signiﬁcant
alterations (Figure 4(b)).
The histological sections of the renal tissue revealed
blood vessels, glomerulus, tubules, and interstice without
signiﬁcant alterations (Figure 5(a)). The liver had normal
morphology, with parenchyma of trophic lobules and an
absence of inﬂammatory inﬁltrations (Figure 5(b)).
None of the sections presented material with characteris-
tics similar with microspheres or giant macrophages.
In the lung sections, (Figure 6) small points of intra-
alveolar hemorrhaging were found in three animals of the
GB group. The rest of the lung tissue had normal histological
standards. The capillary endothelium, basal membrane, in-
terstices, alveolar epithelium, and alveolar macrophages had
no alterations.
3.2. SD Group. In all the parts analyzed referred to the liver,
spleen, and kidney, from this group, no signiﬁcant alteration
was found. A grayish material was identiﬁed on the slide
of the subcutaneous cell tissue from one of the animals.
The location contained exogenous material enveloped by
a hystiocitic reaction. The substance presented ﬁbrillar
characteristics and was located in the interstice and interior
of the macrophages (Figure 7). Microspheres or signs of
ﬁbrosis were not found, which are characteristics of PMMA
implants already described in the literature [5, 6, 8, 10, 13,
14].ISRN Dermatology 5
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Figure 4: Microscopic images observed in the study: (a) right eyeball (magniﬁed 4x) and (b) spleen tissue (magniﬁed 4x).
(a) (b)
Figure 5: Microscopic images. (a) Kidney tissue analyzed (magniﬁed 10x). (b) Liver tissue (magniﬁed 10x).
In the lungs, locations in the lung were found with foamy
histiocytes in alveoli and intra-alveolar hemorrhaging. No
inﬂammatory reaction or signs of pulmonary necrosis were
found in the aﬀected areas.
3.3. IP Group. No alteration was found in the histological
sections of the diaphragms (Figure 8(a)), liver, kidney, and
spleen analyzed. In two animals, congestion was observed in
the histological analysis of the spleen, even if the material
compatiblewithmicrosphereswasnotfoundintheseorgans.
In all the sections containing the lung tissue of the animals
in this group, locations of intra-alveolar hemorrhaging were
observed. In one of these animals, these alterations were
extensive and signiﬁcant (Table 2).
3.4. MPD Group. None of the histological sections of the
liver, kidney, and spleen had signiﬁcant alterations. In the
macroscopic analysis of the musculature, nodulations or
signs of the PMMA implant were not found. The same was
true in the microscopic analysis, where the musculature had
a normal quality (Figure 8(b)), and no microspheres were
found.Inthisgroup,pulmonaryalterationswereobservedin
three of the animals studied (Table 2). The alterations found
in the distinct animals wereas follows:
(i) intra-alveolar hemorrhaging,
(ii) intra-alveolar hemorrhaging with foamy hystocites,
(iii) point of bronchial pneumonia.
None had signs of necrosis or signiﬁcant inﬂammatory
activity.
4. Discussion
The use of PMMA for dermal ﬁllers has grown signiﬁcantly
in Brazil, as well as the number of complications described
that are inherent to their use. Meanwhile, the quantity of
studies and publications about the use of this substance as
a dermal ﬁller has not accompanied the speed of its use,
not only in Brazil. Upon injection under the skin, PMMA
provokes a tissue reaction with a formation of collagenous
tissue and neovascularization around the microsphere [8,
11–15]. According to an experimental study in Wistar rats,6 ISRN Dermatology
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Figure 6: Microscopic images. (a) Lung tissue (magniﬁed 10x). (b) Location of intraalveolar hemorrhaging (increase of 40x).
(a) (b) (c)
Figure 7: Histological section containing amorphous material found in the subcutaneous of one of the animals of the SD group. (a) Deposit
of exogenous material enveloped by histiocytic reaction (magniﬁed 2x). (b) Amorphous ﬁbrillar material in the interstice and interior of the
macrophages (magniﬁed 40x). (c) Fibrillar aspect of exogenous material (magniﬁed 100x).
the process would begin two weeks after the realization of
the implants and continue for months [12].
Inotherstudies,analyzingphagocytosis[15]andtheper-
manence [5] of subdermal implants of Artecoll, the location
of the implant containing PMMA was always easily located.
In another histological study, where one of the authors
applied diﬀerent ﬁllers in his own arm, the Arteﬁll implants
didnotpresentalterationintheinitialvolumeevenafternine
months of evolution, which suggests low or no degradation
or migration of the product [5].
Lemperle et al. [6] describe three mechanisms by which
PMMA microspheres can migrate.
(i) Hematogenic route, by inadvertent injection in a
blood vessel, which can carry microspheres to the
circulatory system. The most probable location of the
ﬁnal destination is the pulmonary capillaries.
(ii) Lymphatic route, by injection in thick lymphatic
vessels. The local lymph nodes and the lungs would
be the most probable ﬁnal destinations. These two
routes, when directly touched by the product, can
serve as an argument for the presence of micro-
spheres in the lymphatic system and in organs such
as the lungs or any other that serves to ﬁlter blood or
the lymphatic system.
(iii) Phagocytosis route microspheres phagocytized by
macrophages can be absorbed at the location of the
implant, later migrating to the local lymph nodes.
The literature consulted created an expectation that
PMMA would be found in the histological sections from
the locations of injection in the SD and MPD groups,
where skin with subcutaneous cell tissue and musculature
of the pelvic membrane, respectively, were analyzed. This
immediately led to reasoning that by injecting the substance
in the free peritoneal and knowing the mechanism for
diaphragmatic absorption, there was a possibility of ﬁnding
these spheres in the diaphragmatic windows. McClelland et
al. [16], in a comparative study between Zyderm (collagen)
and Artecoll applied in guinea pigs, showed that the product
is susceptible to phagocytosis and degradation and can
cause a local inﬂammatory response increasing the signs ofISRN Dermatology 7
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Figure 8: Microscopic images of muscle tissue without signiﬁcant alterations. (a) Diaphragm (magniﬁed 4x). (b) Rear right foot (magniﬁed
10x).
Table 2: Results found after histopathological analysis.
Group N
◦ animal Organ location Lung Liver Kidney Spleen
GB
1 Normal Normal Normal Normal Normal
2N o r m a l A 2 † Normal Normal Normal
3N o r m a l A 2 † Normal Normal Normal
4N o r m a l A 2 † Normal Normal Normal
SD
5N o r m a l A 3 ‡ Normal Normal Normal
6A 1 ∗ Normal Normal Normal Normal
7N o r m a l A 2 † Normal Normal Normal
8 Normal Normal Normal Normal Normal
IP
9N o r m a l A 4 § Normal Normal Normal
10 Normal A2† Normal Normal A6¶
11 Normal A2† Normal Normal Normal
PD
12 Normal A2† Normal Normal A6¶
13 Normal A2† Normal Normal Normal
14 Normal A3‡ Normal Normal Normal
15 Normal A5|| Normal Normal Normal
16 Normal Normal Normal Normal Normal
A1∗: presence of exogenous, ﬁbrillar, and grayish material surrounded by hystiocytic reaction; A2†: small points of intra-alveolar hemorrhaging; A3‡:
locations with foamy hystiocytes in alveolus; A4§: extensive and signiﬁcant intra-alveolar hemorrhaging; A5||: locations of intra-alveolar hemorrhaging. +:
areas with foamy hystiocytes in alveolus. +: point of bronchial pneumonia; A6¶: congested spleen.
immunogenicity of the PMMA particles. In this study, the
guinea pigs also presented transepithelial elimination of the
product, after intradermal application.
Capella [13], in an experimental study with intramuscu-
lar injections of Metacrill in the rear right leg of Wistar rats,
observed alterations in local lymph nodes with histiocytes
containing basophile granulocyte material in cytoplasm. In
this study, the PMMA was identiﬁed in the histological
sections from all of the 16 rats analyzed. Although all of
these possibilities for possible migration were studied, the
experiment did not verify this expectation because PMMA
microspheres were not found in any of the locations inocu-
lated and studied by posterior histopathology. The ﬁndings,
thus, contrast with the literature studied.
Considering this information, four possibilities can be
suggested to explain the fact that PMMA microspheres were
not found in the location of injection in the SD and PD
groups.
(i) The location chosen in the macroscopy for the assem-
blage of histological slides may not include the site of injec-
tion of the material.
Thisisnotverylikelygiventheexperienceofthepatholo-
gistandtheeaseofﬁndingnodulesformedbytheinjectionof
0.2mLofthesubstance,whichindicatestheneedtoassemble
an e wb l o c ko fp a r a ﬃn with the rest of the material and to
conduct a study in series in sections of 4 micrometers.
(ii) The material may be absorbed by phagocytosis and
enzymatic degradation.
(iii) The material may have migrated to other body parts
even if they were not found in the ﬁltering organs.
(iv) The implants contained only the vehicle of the prod-
uct, and the microspheres remained in the syringe used for
application.
The PMMA may have decanted in the syringe. The agi-
tation of the material is not called for by the manufacturer
and was not conducted before the injections. It is relevant8 ISRN Dermatology
that two animals of the PD group had splenetic alterations,
which may be indications of migration of PMMA, by lym-
phatic means. Nevertheless, the single ﬁnding of nonspeciﬁc
splenetic alterations, without PMMA microspheres, is not
suﬃcient evidence to defend the hypothesis of migration of
the inoculated substance.
Concerning the pulmonary alterations found, the intra-
alveolar hemorrhaging found in 12 of the 16 animals is com-
patible with post mortem alterations, given that the animals
were submited to painless death induced by saturation of
ethyl ether, before having their organs removed for analysis.
This can reveal alteration of the pulmonary parenchyma by
the inhalation of supersaturated ethyl ether. The fact that the
animals of all the groups had these alterations reinforces the
theory that they were provoked during their deaths. Other
alterations, such as points of bronchial pneumonia and
foamy histiocytes, observed in two animals, are nonspeciﬁc
alterations and may not be related to the application of
PMMA but to the inhalation of ether.
Many of the published cases of complications with facial
injections of PMMA related to dermal reactions such as ery-
thema and telangiectasia are characterized as complications
resulting from technical errors during the application, when
the implants touch surface planes of the epidermis. There are
also records of formation of granulomas of foreign bodies
with vacuoles and giant cells, where the physiopathology
is still not totally explained. However, it is known that a
2nd and 3rd application of the product can be related to
severe infection or facial trauma [17]. Nevertheless, these
skin alterations cannot be observed in rodents, because they
d on o th a v es u b c u t a n e o u sc e l lt i s s u e .
The inadvertent injection in blood vessels also appears
to be an important complication. Although there are few
published cases, the morbidity of the consequences caused
by this fact is quite high. There is a report of a case
of ophthalmoplegia and total amaurosis after injection of
PMMA in the glabellar region of a previously healthy patient
[18]. Although puncture was tested in all of the inoculations
withthereturnofbloodtothesyringe,inratswithoutsubcu-
taneous tissue, the vascular network is certainly diminished,
and there is a lower probability of one of these structures
being punctured. In addition, the vascular volume of rodents
of this weight is quite limited.
Most of the aesthetic facial implants of PMMA take
place in deep reticular dermis and at the dermal-subdermal
junction,wherethereisanintensevenousandlymphaticnet-
work.
The diameter of the vessels of this region vary from
35 to 120µm (veins) and 30–100µm (lymphatic), which is
suﬃcient to carry the PMMA microspheres. In the skin,
especially that of the face, there is a network so dense that,
theoretically,anypunctureinthislocationwindsupaﬀecting
one of these vessels [6]. Seeking to avoid vascular lesions,
there are authors who defend the use of microcannulas
instead of needles with sharp points [19].
In this study, hypodermic needles were used with sharp
points and no sign of necrosis or vascular damage was found
in the sections of the eyeball and others analyzed. No signs
of rejection or extensive inﬂammatory process was found in
any of the implants of the study.
In the bibliography studied, no studies were found
that detail the exact composition and the real size of the
microspheres found in the options for aesthetic facial ﬁlling
sold in Brazil. It is important to have quality control of
the PMMA substances, given that previous studies have
shown that microspheres with diameters lower than 15µm
are susceptible to phagocytosis and the impurities are related
to exacerbated inﬂammatory reactions [6, 7, 20]. In Europe,
publications such as that of McClelland et. al., which
demonstrate irregularities in the composition of PMMA
produced by Artes Medical, led to improvements in the
substance with new puriﬁcation processes. There are various
studies that show the biocompatibility of PMMA. A perfect
spherical form, the purity of the product and the neutrality
of the electric charge are characteristics that cause the
microspheres to resist phagocytosis [15].
Microspheres were not found in any of the sections made
from the ﬁltering organs in any of the animals studied. The
analysis of only one section, which encompasses a small area
of each organ, made it diﬃcult to detect small microspheres
of approximately 40µm in diameter. The results encountered
were not in keeping with those cited in the literature.
No signs of PMMA were found in any of the animals
studied. Only one of the sections of SD had a nonidentiﬁed
amorphous material not compatible with the characteristics
already well described for PMMA implants.
Giventhatthisistheﬁrststepofastudyconductedbythe
Plastic Surgery Center of the University Hospital at UFSC,
and the initiation of a line of research about the subject
in our ﬁeld, it is hoped that this study will help spark the
curiosity of those who use the product, contributing to the
scientiﬁc understanding of the behavior in vivo of implants
of Polymethylmetacrylate available in Brazil. Therefore, the
conclusion obtained in this experiment reveals that in the
histopathological analysis of this work, no microspheres of
PMMA were found in any of the tissues studied.
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